Current Report · Items 7.01, 9.01 · 8-K
BIO-key International, Inc.
Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On July 7, 2026, BIO-key International, Inc. (the “Company”) issued a press release regarding the reinstatement of trading of the Company’s common stock on the Nasdaq Capital Market. A copy of the press release is attached to this Form 8-K as Exhibit 99.1 and incorporated herein by reference.…
Filed Jul 7, 2026Accepted Jul 7, 2026, 8:45 AM EDTCIK 1019034Accession 0001437749-26-022880
Company context
Current securities
Historical securities (8)
Registered securities in this filing
BIO-key International, Inc. · 8-K · Filed 2026-07-07
As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.
Common Stock
- Symbol
- BKYI
- Exchange
- NASDAQ
- Classification
- COMMON
Filing context
Context: d20268K
Dimensions: Not supplied
Accession 000143774926022880 · 1 registered-security cover member
Read the exact SEC filing ↗Disclosure sections
Items 7.01, 9.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
On July 7, 2026, BIO-key International, Inc. (the “Company”) issued a press release regarding the reinstatement of trading of the Company’s common stock on the Nasdaq Capital Market. A copy of the press release is attached to this Form 8-K as Exhibit 99.1 and incorporated herein by reference.
In accordance with General Instruction B.2 of Form 8-K, the information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such a filing.